Antiproteinuric effect of oral paricalcitol in chronic kidney disease

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

Aram V. Chobanian · JAMA · 2003 · 25.6K citations

Medicine, Cardiology, Geriatric Medicine +17

A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation

Andrew S. Levey, Juan Bosch, Julia B. Lewis et al. · Annals of Internal Medicine · 1999 · 15.1K citations

Medicine, Biostatistics, Nephrology +17

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

Barry M. Brenner, Mark E. Cooper, Dick de Zeeuw et al. · New England Journal of Medicine · 2001 · 7.5K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes

Edmund J. Lewis, Lawrence G. Hunsicker, William R. Clarke et al. · New England Journal of Medicine · 2001 · 6K citations · Full text

Medicine, Nephrology, Pharmacology +16

1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system

Yan Chun Li, Juan Kong, Minjie Wei et al. · Journal of Clinical Investigation · 2002 · 1.8K citations · Full text

Medicine, Endocrinology, Physiology +15